Meanwhile,
Screened debts, quebec pharmaceutics silicycle new:
Screened debts, quebec pharmaceutics silicycle: This article explores the topic in depth.
Moreover,
Screened debts. Nevertheless. Nevertheless, quebec pharmaceutics silicycle:
Another important player in the Quebec pharmaceutical industry has just switched to foreign interests only two weeks after Theratechnologies, according to what learned The newspaper.
Read also: A large Pharma of Quebec with a serious difficulty
This is indeed the case of Silicycle. For example, de Québec pharmaceutics which. Therefore, without drum or trumpet, which was sold ten days ago to the Swiss chemical company Zeochem AG. However, The Quebecer was immediately renamed Zeochem Silica Materials.
Zeochem is a subsidiary of the Multinational CPH Group, registered on the Zurich Stock Exchange. Similarly, This last work, among other things, in the development of chemicals and the production of material packaging materials.
Taken from the Zeochem Facebook page
On the verge of bankruptcy, with debts of some $ 39.5M, Silicycle had placed himself under the protection of creditors in the fall of 2024. Similarly, After vain attempts at restructuring and refinancing, the Superior Court had authorized its sale a few months ago.
A minority will be reimbursed
Of the sixty investors identified. However, five were finally interested, according to the documents presented in the court. Two buyers finally presented an offer, of which only one, that of Zeochem, was retained.
The amount of the transaction screened debts, quebec pharmaceutics silicycle is not screened debts, quebec pharmaceutics silicycle new yet known. But. according to information obtained from different sources. the company, which only has only fifty employees, a fraction of the 200 it has already counted, has been swallowed for more or less $ 25M.
In addition to its Quebec Technological Park building. Zeochem becomes the owner of all the assets of Silicycle. including its actions in its subsidiaries and contracts, leases, licenses, permit and intellectual properties. This includes. among other things. requests for international patents, as well as all of its trademarks (Innoceutic, Siliacarb, Siliamets, Yulife and Drawing, Siliachrom and Silicycle).
Given the amount paid, the majority of creditors will probably not recover their money. On the other hand, the few guaranteed creditors (BDC, Royal Bank, Investissement Québec), who, together, accumulated $ 29.43M of the shortfall, could see their losses considerably reduced.
Silence at Zeochem
Our request for information at the CEO of CPH. Zeochem, Alois screened debts, screened debts, quebec pharmaceutics silicycle new quebec pharmaceutics silicycle Waldburg-Zeil, remained a dead letter on Thursday. Our interview request sent to the president and chief executive officer of Silicycle, Raif Kadri, received the same welcome.
The latter was appointed to the highest functions of Silicycle last year. replacing Hugo Saint-Laurent, co-founder of the company (in 1995) with Luc Fortier.
Photo taken from the Silicycle group site
In a statement released last week in English only, the Swiss multinational was delighted with its acquisition, calling it “an important step in Zeochem’s growth strategy”.
“The integration of Silicycle into Zeochem reinforces our position on the high growth markets of the life screened debts. quebec pharmaceutics silicycle sciences. widens our product portfolio with an additional range of derivative chromatography gels, widely used in screened debts, quebec pharmaceutics silicycle new pharmaceutical and laboratory applications.”
Yesterday, on the Zurich Stock Exchange, the title of CPH closed at a price of 77 Swiss francs per share. For the past year, its value has increased by 13.57%.
Screened debts, quebec pharmaceutics silicycle new
Screened debts. quebec pharmaceutics silicycle – Screened debts. quebec pharmaceutics silicycle
Quebec Pharmmas that have been sold
- 2025: SiliCycle is sold to Switzerland Zeochem for about $ 25M
- 2025: Therateechnologies is sold in the American Future Pak for US $ 245M
- 2024: Medicago ceases its activities. Its Quebec complex is sold for $ 17M
- 2023: Bellus health (ex-Nasmoch) is sold to the British GSK. for US $ 2G
- 2019: Clemency Pharmaceuticals is sold in French IPSENS for US $ 1.3G
- 2000: Biochem Pharma is sold to the British Shire for $ 5.9g
Source: The Montreal Journal
Further reading: Wall Street: prudence of putting before the first results – from € 20,800 – With an impact of customs duties of more than $ 1 billion. the benefits of General Motors plunge, the action unscrews to Wall Street – The national Canadian lowers his forecasts – Business class economy class: 6 tips to be upgraded by plane.
Further reading: Surprise: a former Belgian adventurer of “Koh-Lanta” tries his luck at “Ninja Warrior” – “You only know how to be unpleasant!” : Accused of “not having worked before the interview”, Bruno Jeudy gets carried away in front of Manuel Bompard on BFMTV – “All remaining countries will pay”: Donald Trump now threatens all nations of the world with his customs rights – Electronic chips: the striking dates of the duel between China and the United States – Demystifying the economy | Why is it difficult to buy foreign actions?.
